THROMBOLYSIS USING PLASMINOGEN-ACTIVATOR AND HEPARIN REDUCES CEREBRALNO-REFLOW AFTER RESUSCITATION FROM CARDIAC-ARREST - AN EXPERIMENTAL-STUDY IN THE CAT
M. Fischer et al., THROMBOLYSIS USING PLASMINOGEN-ACTIVATOR AND HEPARIN REDUCES CEREBRALNO-REFLOW AFTER RESUSCITATION FROM CARDIAC-ARREST - AN EXPERIMENTAL-STUDY IN THE CAT, Intensive care medicine, 22(11), 1996, pp. 1214-1223
Objective: Successful resuscitation of the brain requires complete mic
rocirculatory reperfusion, which, however, may be impaired by activati
on of blood coagulation after cardiac arrest. The study addresses the
question of whether postischemic thrombolysis is effective in reducing
cerebral no-reflow phenomenon. Design: 14 adult normothermic cats wer
e submitted to 15-min cardiac arrest, followed by cardiopulmonary resu
scitation (CPR) and 30 min of spontaneous recirculation. The CPR proto
col included closed-chest cardiac massage, administration of epinephri
ne 0.2 mg/kg, bicarbonate 2 mEq/kg per 30 min, and electrical defibril
lation shocks. Interventions: During CPR, animals in the treatment gro
up (n = 6) received intravenous bolus injections of 100 U/kg heparin a
nd 1 mg/kg recombinant tissue type plasminogen activator (rt-PA), foll
owed by an infusion of rt-PA 1 mg/kg per 30 min. Measurements and resu
lts: Microcirculatory reperfusion of the brain was visualized by label
ing the circulating blood with 300 mg/kg of 15% fluorescein isothiocya
nate albumin at the end of the recirculation period. Areas of cerebral
no-reflow - defined as the absence of microvascular filling - were id
entified by fluorescence microscopy at eight standard coronal levels o
f forebrain, and expressed as the percentage of total sectional area.
One animal in the treatment group was excluded from further analysis b
ecause of intracerebral hemorrhage due to brain injury during trepanat
ion. Autopsy revealed the absence of intracranial, intrathoracic, or i
ntra-abdominal bleeding in all the other animals. In untreated animals
(n = 8), no-reflow affected 28 +/- 13% of total forebrain sectional a
reas, and only 1 out of 8 animals showed homogenous reperfusion (i.e.,
no-reflow < 15% of total forebrain sectional areas). Thrombolytic the
rapy (n = 5) significantly reduced no-reflow to 7 +/- 5% of total fore
brain sectional areas and all treated animals showed homogeneous reper
fusion at the microcirculatory level. Conclusions: The present data de
monstrate that thrombolytic therapy improves microcirculatory reperfus
ion of the cat brain when administered during reperfusion after cardia
c arrest.